GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
7UAI | Q16819 | Meprin alpha helix in complex with fetuin-B | |
3IAI | Q16790 | Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX | |
6Y74 | Q16790 | X-ray crystal structure of human carbonic anhydrase IX catalytic domain. | |
3SI0 | Q16769 | Structure of glycosylated human glutaminyl cyclase | |
5SC8 | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 17 | |
5SC9 | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 29 | |
5SCA | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 36 | |
5SCB | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 28 | |
5SCC | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 57 | |
5SCD | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 58 | |
5SCE | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 55 | |
5SCF | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 99 | |
5SCG | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 101 | |
5SCH | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 100 | |
5SCI | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 105 | |
5SCJ | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 106 | |
5SCK | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 42 | |
5SCL | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 1 | |
5SDT | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 15 | |
7L0J | Q16671 | Structure of AMH bound to AMHR2-ECD | |
3B6H | Q16647 | Crystal structure of human prostacyclin synthase in complex with inhibitor minoxidil | |
2FO4 | Q16615 | Enhanced MHC class I binding and immune responses through anchor modification of the non-canonical tumor associated MUC1-8 peptide | |
6UXO | Q16611 | Crystal structure of BAK core domain BH3-groove-dimer in complex with DDM | |
6D1U | Q16602 | Crystal structure of the human CLR:RAMP1 extracellular domain heterodimer in complex with adrenomedullin 2/intermedin | |
6ZHO | Q16602 | Crystal structure of a CGRP receptor ectodomain heterodimer with bound high affinity inhibitor | |
6ZIS | Q16602 | Crystal structure of a CGRP receptor ectodomain heterodimer with bound high affinity inhibitor | |
5V6Y | Q16602 | Crystal structure of the human CLR:RAMP1 extracellular domain heterodimer with bound high-affinity and altered selectivity adrenomedullin variant | |
6V2E | Q16602 | Crystal structure of the human CLR:RAMP2 extracellular domain heterodimer with bound high-affinity adrenomedullin S45R/K46L/S48G/Q50W variant | |
7P0F | Q16602 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0028125 | |
7P0I | Q16602 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor Compound 13 | |
4RWF | Q16602 | Crystal structure of the CLR:RAMP2 extracellular domain heterodimer with bound adrenomedullin | Maltose transporter subunit, Receptor activity-modifying protein 2, Calcitonin gene-related peptide type 1 receptor fusion protein, adrenomedullin |
4RWG | Q16602 | Crystal structure of the CLR:RAMP1 extracellular domain heterodimer with bound high affinity CGRP analog | |
8AX5 | Q16602 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0029881 | |
8AX6 | Q16602 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0029882 | |
8AX7 | Q16602 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0031448 | |
4HSA | Q16552 | Structure of interleukin 17a in complex with il17ra receptor | Interleukin-17A, Interleukin-17 receptor A |
5N92 | Q16552 | Crystal Structure of Human IL-17AF | Interleukin-17A, Interleukin-17F |
5NAN | Q16552 | Crystal Structure of human IL-17AF in complex with human IL-17RA | |
7UWM | Q16552 | Structure of the IL-17A-IL-17RA binary complex | |
7UWN | Q16552 | Structure of the IL-17A-IL-17RA-IL-17RC ternary complex | |
7ZAN | Q16552 | Crystal Structure of human IL-17A in complex with IL-17RA and IL-17RC | |
5TCO | Q16539 | Human p38 MAP Kinase in Complex with Dibenzosuberone Compound 1 | |
6HWU | Q16539 | Crystal structure of p38alpha in complex with a photoswitchable 2-Azothiazol-based Inhibitor (compound 2) | |
6HWT | Q16539 | Crystal structure of p38alpha in complex with a reduced photoswitchable 2-Azothiazol-based Inhibitor (compound 31) | |
6QYX | Q16539 | p38(alpha) MAP kinase with the activation loop of ERK2 | |
6HWV | Q16539 | Crystal structure of p38alpha in complex with a photoswitchable 2-Azoimidazol-based Inhibitor (compound 3) | |
1ZYJ | Q16539 | Human P38 MAP Kinase in Complex with Inhibitor 1a | |
1ZZ2 | Q16539 | Two Classes of p38alpha MAP Kinase Inhibitors Having a Common Diphenylether Core but Exhibiting Divergent Binding Modes | |
2FSL | Q16539 | mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-A | |
2FSM | Q16539 | mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-B |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024